| Naziv: | Real-World Safety of Vedolizumab in Inflammatory Bowel Disease: A Retrospective Cohort Study Supported by FAERS Signal Analysis |
Autori: | Milašinović, Bojana   ; Vezmar-Kovačević, Sandra ; Marković, Srđan ; Jovanović, Marija ; Knežević-Ivanovski, Tamara; Kralj, Ðorđe; Svorcan, Petar ; Miljković, Branislava ; Vučićević, Katarina |
Godina: | 2025 |
Publikacija: | Pharmaceuticals |
ISSN: | 1424-8247 Pharmaceuticals Pretraži identifikator |
Izdavač: | Basel, Switzerland : MDPI |
Tip rezultata: | Naučni članak |
Kolacija: | vol. 18 br. 8 str. 1127 |
DOI: | 10.3390/ph18081127 |
WoS-ID: | 001557527400001 |
Scopus-ID: | 2-s2.0-105014440932 |
PMID: | 40872519 |
PMCID: | PMC12389730 |
URI: | https://enauka.gov.rs/handle/123456789/998378
https://farfar.pharmacy.bg.ac.rs/handle/123456789/6228 |
URL: | https://www.mdpi.com/1424-8247/18/8/1127 |
Projekat: | optYmAb - Improving Clinical Outcomes with Precision Dosing in Patients with Inflammatory Bowel Disease Through Investigating Variability of Monoclonal Antibodies Based on Population Pharmacokinetic-Pharmacodynamic Modeling |
M-kategorija: | 21aM21a - Vodeći međunarodni časopis kategorije M21a |
